Cochrane Abstracts
Linezolid versus vancomycin for skin and soft tissue infections
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Linezolid Versus Vancomycin for Skin and Soft Tissue Infections." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439453/all/Linezolid_versus_vancomycin_for_skin_and_soft_tissue_infections.
Linezolid versus vancomycin for skin and soft tissue infections. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439453/all/Linezolid_versus_vancomycin_for_skin_and_soft_tissue_infections. Accessed March 27, 2025.
Linezolid versus vancomycin for skin and soft tissue infections. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439453/all/Linezolid_versus_vancomycin_for_skin_and_soft_tissue_infections
Linezolid Versus Vancomycin for Skin and Soft Tissue Infections [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439453/all/Linezolid_versus_vancomycin_for_skin_and_soft_tissue_infections.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Linezolid versus vancomycin for skin and soft tissue infections
ID - 439453
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439453/all/Linezolid_versus_vancomycin_for_skin_and_soft_tissue_infections
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
